How E-connected medicine will change the value of pharmaceuticals. Overview of current initiatives on digital pill

Size: px
Start display at page:

Download "How E-connected medicine will change the value of pharmaceuticals. Overview of current initiatives on digital pill"

Transcription

1 How E-connected medicine will change the value of pharmaceuticals Overview of current initiatives on digital pill Professor Mondher Toumi Aix Marseille University ISPOR Asia Pacific 08 Agenda Burden of non compliance Overview of the potential advantages of current digital pills initiative from various perspectives Patient Caregiver Doctor Provider Effectiveness and efficiency and consideration in HTA evaluation

2 Burden of non compliance Recent study estimated that the annual adjusted disease-specific economic cost of non-adherence per person ranged from $949 to $44 90 (in 05 US$) Rachelle Louise Cutler et al. BMJ Open 08;8:e0698 Simple initiative often not sufficient A very large randomized clinical trial ( enrollees of a pharmacy benefit manager) did not show a statistically significant difference in adherence was found between those in the control group and those who received a reminder device (pill bottle strip with toggles, digital timer cap, or standard pillbox) JChoudhry NK. Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial. JAMA Intern Med. 07 May ;77(5):64-63.

3 Current initiatives Severe Mental Illness In 07 U.S. regulators approved the first medicine with an embedded sensor to help keep track of whether patients with mental illness are adhering to their prescriptions. Hepatitis C,3 Denver Health is conducting study using digital pill to track adherence and compliance of Hepatitis, a viral disease that impacts the liver and can be fatal but is also curable through often expensive medicines. Opioids 3 Denver Health is conducting study using digital pill to track adherence and compliance Chai et al. Med Internet Res. 07 Jan 3;9()Digital Pills to Measure Opioid Ingestion Patterns in Emergency Department Patients With Acute Fracture Pain: A Pilot Study. Severe Mental Illness Principle of Digital medicine system (DMS) Neuropsychiatric Disease and Treatment 08:

4 Benefits (/) The pill will allow doctors to track better than ever how well people stick to a course of medication. Understand the reason for poor efficacy Will support the caregiver in helping patient monitoring treatment intake and decrease anxiety of caregiver on patient s compliance Dialogue on adherence and reassurance May also discover vital new information about treating hepatitis C or SMIR and respond to the question on how often you need to take your hepatitis C or SMI medication to be cured Infor; development strategy and new vision of adherence Benefits (/) For opioid determining adherence to a prescribed medication regimen and measuring the ways in which patients ingest asneeded medications pose methodological challenges with usual methods patients determine opioid ingestion dose and frequency based on temporal perception of pain thus common measures of adherence (eg, smart pill bottles, pharmacy refill histories, or patient diaries) are impractical or provide aggregate measures that cannot delineate temporal patterns of opioid ingestion. Precise measures of opioid ingestion patterns are important because they can suggest incomplete treatment of pain, the development of tolerance, or the transition into problematic use Chai et al. Med Internet Res. 07 Jan 3;9()Digital Pills to Measure Opioid Ingestion Patterns in Emergency Department Patients With Acute Fracture Pain: A Pilot Study. DN, Dhalla IA. Dependence and addiction during chronic opioid therapy. J Med Toxicol. 0 Dec;8(4):

5 Concern DMS can be seen as a form of surveillance and may be experienced as intrusive, coercive, or an invasion of privacy by people who experience mental illness There are legitimate reasons people may be mindfully nonadherent to prescribed medication regimens, such as psychological resistance to treatment, wishes to avoid undesirable side effects burdensome medication costs, a lack of trust in providers advice, and treatment goals that may conflict with those of their providers including attempts to decrease medication use. Behavioral psychology acceptability Absent strict legal orders, people have the right to manage their medications without oversight or covert pressure. Dotolo D et al. A Hard Pill to Swallow: Ethical Problems of Digital Medication. Soc Work. 08 Aug. Discussion Digital pill is a promising new tool that Should be mandatory in clinical trials could benefit patients, caregiver and doctors Open a new field of the most important clinical pharmacology topic Enhance value for payer and society Will allow researchers to understand better the use of medications in a unprecedented way that could influence the development of new drugs However ethical concerns must be consider so this tool does not become a coercive tool 5

Adherence & Medicaton review

Adherence & Medicaton review Adherence & Medicaton review Assoc. Prof. Mitja Kos, Ph.D., M.Pharm. Head, Chair of Social Pharmacy University of Ljubljana, Faculty of Pharmacy, Web: www.ffa.uni-lj.si E-mail: mitja.kos@ffa.uni-lj.si

More information

Digital Technologies: The Solutions to Poor Medication Adherence?

Digital Technologies: The Solutions to Poor Medication Adherence? Digital Technologies: The Solutions to Poor Medication Adherence? Jeffrey Mesaros, PharmD Annual Meeting & Exposition Seattle, Washington March 22-25 1 Disclosures The views and opinions expressed in the

More information

Medication Management When Caring for Seniors at Home

Medication Management When Caring for Seniors at Home Medication Management When Caring for Seniors at Home White Paper May 24, 2013 2013 Physician s Choice Private Duty http://private-duty.pchhc.com 1 Proper medication management for seniors who live at

More information

Adherence. (Last update: June 2018) Together, we can change the course of the HIV epidemic one woman at a time.

Adherence. (Last update: June 2018) Together, we can change the course of the HIV epidemic one woman at a time. Adherence (Last update: June 2018) Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject Strong Drugs to Fight HIV Advances in HIV treatment in past

More information

Non adherence with analgesics. Dr Susan Salt, Medical Director, Trinity Hospice

Non adherence with analgesics. Dr Susan Salt, Medical Director, Trinity Hospice Non adherence with analgesics Dr Susan Salt, Medical Director, Trinity Hospice Overview Definitions Extent of the problem Possible mechanisms Why it is challenging A common sense approach Everyone s responsibility

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Int Med. Published online February

More information

Assessing Medication Adherence

Assessing Medication Adherence Assessing Medication Adherence Dr. Lauren Hanna and Dr. Delbert Robinson Northwell Health National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental

More information

Industry Perspective on Formulation and Packaging Considerations

Industry Perspective on Formulation and Packaging Considerations Industry Perspective on Formulation and Packaging Considerations Ron Ogilvie (Pfizer) EFPIA February 2012 1 Industry Perspective on Formulation and Packaging Considerations Provide an overview of formulation

More information

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse

More information

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Utah. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view

More information

therapy among HIV positive youth, Uganda

therapy among HIV positive youth, Uganda Measuring adherence to antiretroviral therapy among HIV positive youth, Uganda Gertrude Nakigozi, MBChB, MPH, PhD 2 nd annual conference on Global Perspectives on economic strengthening and adolescent

More information

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration Teaming Up for Safer Pain Management: Strategies for Effective Collaboration Noah Nesin, MD, FAAFP, Vice President of Medical Affairs, Penobscot Community Health Care Felicity Homsted, PharmD, DPLA, Chief

More information

2/20/2019. Source: Source:

2/20/2019. Source:   Source: The misuse of and addiction to opioids including prescription pain relievers, heroin, and synthetic opioids such as fentanyl is a serious national crisis that affects public health as well as social and

More information

Cutting edge solution for patient adherence in clinical trials

Cutting edge solution for patient adherence in clinical trials Cutting edge solution for patient adherence in clinical trials Medicodose s patented smart pharmaceutical packaging and adherence platform Enable real-time and simultaneous remote patient monitoring Allow

More information

Prescription Drug Safety for Teens

Prescription Drug Safety for Teens Prescription Drug Safety for Teens Curriculum Guide Recommended Grade Level 9-12 Total Time 30-45 minutes Subject Fit Health Standards Alignment National Health Education Standards (NHES) With prescription

More information

Strategies for Managing Your Medications

Strategies for Managing Your Medications for Managing Your Medications This guide offers some strategies that can help you with your medication use. If any issue applies to you, talk to your health care provider (HCP) about using one or more

More information

Prescription Drug Abuse Among the Disabled

Prescription Drug Abuse Among the Disabled Prescription Drug Abuse Among the Disabled As of 2006, the U.S. Department of Health and Human Services Office on Disability estimated that 4.7 million adults experienced a substance abuse problem in addition

More information

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Sorin Buga, MD Associate Clinical Professor Department of Supportive Care City of Hope National Medical Center SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Click to edit Master Presentation Date Disclosure

More information

Methods to Diagnose Adherence Status

Methods to Diagnose Adherence Status Methods to Diagnose Adherence Status March 4, 2014 Andrew G Weinstein MD Associate Clinical Professor Pediatrics Jefferson Medical College President, Adherence Management Systems Disclosures President,

More information

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Objectives Identify patient barriers to medication adherence. Describe the clinical and economic impact of

More information

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted

More information

The Nanos Survey on Drug Affordability is Flawed. Here s Why.

The Nanos Survey on Drug Affordability is Flawed. Here s Why. The Nanos Survey on Drug Affordability is Flawed. Here s Why. Michael Law (michael.law@ubc.ca) and Ashra Kolhatkar March 6, 2018 Background Last month, with colleagues we published the largest study to

More information

Strategies To Maintain Independence In The Elderly

Strategies To Maintain Independence In The Elderly Strategies To Maintain Independence In The Elderly Laura Seriguchi, RN Guardian Medical Monitoring, Inc. And in the end, it s not the years in your life that count, it s the life in your years. ABRAHAM

More information

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010 The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010 EXECUTIVE SUMMARY It is well documented in multiple

More information

Y. W. Francis Lam, Pharm.D. FCCP University of North Texas Health Science Center Grand Round Rx to OTC Switch: Potentials, Challenges, and Initiatives

Y. W. Francis Lam, Pharm.D. FCCP University of North Texas Health Science Center Grand Round Rx to OTC Switch: Potentials, Challenges, and Initiatives 1 Rx to OTC Switch Potentials, Challenges, and Initiatives Y. W. Francis Lam, Pharm.D., FCCP Professor of Pharmacology lamf@uthscsa.edu, 7-8355 Educational Goal Attendees will have an overall understanding

More information

The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose

The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose 1 Learning Objectives Identify pain treatment related regulatory agencies Discuss the changing role of regulatory

More information

Medication Use Questionnaire

Medication Use Questionnaire Medication Use Questionnaire This questionnaire will help you think about how you use your medications. When thinking about your medications include: Prescriptions Over the counter drugs Homeopathic medicines

More information

Retention and adherence: evidence-based strategies. Dr Catherine Orrell Desmond Tutu HIV Centre

Retention and adherence: evidence-based strategies. Dr Catherine Orrell Desmond Tutu HIV Centre Retention and adherence: evidence-based strategies. Dr Catherine Orrell Desmond Tutu HIV Centre Adherence in sub-saharan Africa 3 large reviews of the antiretroviral adherence literature to date: Bärnighausen,

More information

One State s Perspective on the Management of Hepatitis C Drugs. February 27, 2015 Pavel Lavitas, PharmD, BCPS Clinical Consultant Pharmacist

One State s Perspective on the Management of Hepatitis C Drugs. February 27, 2015 Pavel Lavitas, PharmD, BCPS Clinical Consultant Pharmacist One State s Perspective on the Management of Hepatitis C Drugs Pavel Lavitas, PharmD, BCPS Clinical Consultant Pharmacist Statement of Disclosure I have no relevant financial relationships that would be

More information

Hepatitis C at W 17th St Family Practice

Hepatitis C at W 17th St Family Practice Hepatitis C at W 17th St Family Practice Identifying population needs and proposing a clinical workflow Meg Glausser, Regina Ginzburg, Shireen Farzadeh, You Jin Chang, Michelle Bejar Background & Rationale

More information

REAL WORLD DATA GENERATION FOR MARKET ACCESS PURPOSES. Marcin Balcerzak Research Team Lead Farenta Oy

REAL WORLD DATA GENERATION FOR MARKET ACCESS PURPOSES. Marcin Balcerzak Research Team Lead Farenta Oy REAL WORLD DATA GENERATION FOR MARKET ACCESS PURPOSES Marcin Balcerzak Research Team Lead Farenta Oy AGENDA Real world evidence in market access landscape: demands & requirements Case studies: Product

More information

Improving medication compliance with ingestible sensors

Improving medication compliance with ingestible sensors Improving medication compliance with ingestible sensors BHI 505: Digital Health Presentation By: Joseph Miles, PharmD Reference Moorhead, P., Zavala, A., Kim, Y., & Virdi, N. S. (2017). Science and Practice:

More information

From the Clinic to Home: The Shift to Oral Oncolytic Therapy

From the Clinic to Home: The Shift to Oral Oncolytic Therapy From the Clinic to Home: The Shift to Oral Oncolytic Therapy Eric Vachon, BSN, RN Michigan State University, College of Nursing Disclosure I do not have anything to disclose. Objectives Oral oncolytics

More information

Practical Points from a Residency Clinic. Susan Faragher Bannon, MD, FACP Medical Director Department of Internal Medicine WMU School of Medicine

Practical Points from a Residency Clinic. Susan Faragher Bannon, MD, FACP Medical Director Department of Internal Medicine WMU School of Medicine Practical Points from a Residency Clinic Susan Faragher Bannon, MD, FACP Medical Director Department of Internal Medicine WMU School of Medicine Dr. Bannon has no financial relationships or conflicts of

More information

Opioid Initiative Wave I PDMPs and Screening

Opioid Initiative Wave I PDMPs and Screening Opioid Initiative Wave I PDMPs and Screening Presenter Jason Hoppe, DO PDMPs and Screening Jason Hoppe, DO Department of Emergency Medicine University of Colorado School of Medicine Take away points Embrace

More information

Apurba Chakraborty MBBS, MPH Dima M. Qato PharmD, MPH, PhD Professor Mark S. Dworkin MD, MPHTM The University of Illinois at Chicago

Apurba Chakraborty MBBS, MPH Dima M. Qato PharmD, MPH, PhD Professor Mark S. Dworkin MD, MPHTM The University of Illinois at Chicago Less is More: The Impact of Lower Pill Burden on Adherence to Antiretroviral Therapy among Treatment-Naive Patients with HIV Infection in the United States Apurba Chakraborty MBBS, MPH Dima M. Qato PharmD,

More information

Watching and waiting : what it means for patients. Dr Christian Aldridge Consultant Dermatologist Cwm Taf NHS Trust

Watching and waiting : what it means for patients. Dr Christian Aldridge Consultant Dermatologist Cwm Taf NHS Trust Watching and waiting : what it means for patients Dr Christian Aldridge Consultant Dermatologist Cwm Taf NHS Trust Watching and waiting or...watching and worrying Once you have a cancer diagnosis, you

More information

Monitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH

Monitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH 1 Monitoring Protocol for Clozapine-induced Myocarditis 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives

More information

Evidence-based ART adherence. Dr Catherine Orrell Desmond Tutu HIV Foundation 26 November 2012

Evidence-based ART adherence. Dr Catherine Orrell Desmond Tutu HIV Foundation 26 November 2012 Evidence-based ART adherence Dr Catherine Orrell Desmond Tutu HIV Foundation 26 November 2012 What is adherence? There are two main components: 1) Adherence to daily treatment All tablets taken At the

More information

A Gathering Storm: Evaluating Perioperative Opioids

A Gathering Storm: Evaluating Perioperative Opioids A Gathering Storm: Evaluating Perioperative Opioids Michael Bottros, MD Disclosure Nothing to disclose 1 Objectives Describe the history of opioid prescribing practices in the United States Describe the

More information

ENHANCING MEDICATION SAFETY:

ENHANCING MEDICATION SAFETY: ENHANCING MEDICATION SAFETY: Conversations with Patients and Caregivers Lisa Sever, BSc PHM, ACPR, CGP, RPh What medications are you taking? Seems to be a relatively straight forward question.. Or is it??

More information

Powering mhealth. IM Associates. October 2016

Powering mhealth. IM Associates. October 2016 Powering mhealth IM Associates October 2016 Background Many of our customers are looking to increase knowledge about the patients, the patient flow, treatment decision, Many questions are dealing with

More information

Leverage Healthcare Technology Applications to Improve Primary Nonadherence.

Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Page 2 Medication adherence starts with assessing a patient s opportunity for having positive outcomes on a specific therapy.

More information

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP Overview Gavin Foundation Injectable naltrexone Community report

More information

ADHERENCE TO TREATMENT

ADHERENCE TO TREATMENT ADHERENCE TO TREATMENT Understanding and supporting patients John Weinman & Zoe Moon King s College London OVERVIEW OF TALK - The Adherence problem and its effects - Adherence issues in cancer treatment

More information

Adherence in adolescents- what works? Audrey Pettifor PhD University of North Carolina at Chapel Hill

Adherence in adolescents- what works? Audrey Pettifor PhD University of North Carolina at Chapel Hill Adherence in adolescents- what works? Audrey Pettifor PhD University of North Carolina at Chapel Hill ART Coverage Rates by Age Band UNAIDS 2016 Report Zanoni and Mayer. AIDS Patient Care STDS. 2014 Mar

More information

Views of general practitioners and pharmacists on the role of the pharmacist in HIV/Aids management

Views of general practitioners and pharmacists on the role of the pharmacist in HIV/Aids management Views of general practitioners and pharmacists on the role of the pharmacist in HIV/Aids management Van der Walt E, BPharm, MSc (Med) (MEDUNSA), PhD (MEDUNSA) Previously a postgraduate student at the School

More information

Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy. Pharmacists Role 1

Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy. Pharmacists Role 1 Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy Pharmacists Role 1 Promotion of health improvement, wellness, and disease prevention in cooperation

More information

Colorado State Board of Medical Examiners Policy

Colorado State Board of Medical Examiners Policy POLICY NUMBER: 10-14 Title: Guidelines for the Use of Controlled Substances for the Treatment of Pain Date Issued: May 16, 1996 Date(s) Revised: November 18, 2004 Reference: 12-36-117, C.R.S. Purpose:

More information

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014 Maintaining Patient Safety When Chronic Opioid Therapy Is Prescribed P. David Pacheco, Ph.C, PA-C, CAAAPM Pain Medication Management Specialist Southwest Interventional Pain Specialists, PC 4700 Jefferson

More information

The Sustainability of Irish Pharmaceutical Expenditure. Valerie Walshe Ph.D. Economist

The Sustainability of Irish Pharmaceutical Expenditure. Valerie Walshe Ph.D. Economist The Sustainability of Irish Pharmaceutical Expenditure Valerie Walshe Ph.D. Economist valerie.walshe@hse.ie February 2015 Content Overview of Irish Health Services Community Drug Prescribing Trends Driving

More information

Strategies for Federal Agencies

Strategies for Federal Agencies Confronting Pain Management and the Opioid Epidemic Strategies for Federal Agencies Over the past 25 years, the United States has experienced a dramatic increase in deaths from opioid overdose, opioid

More information

Prescription Switching and Reduced LDL-C Goal Attainment

Prescription Switching and Reduced LDL-C Goal Attainment Prescription Switching and Reduced LDL-C Goal Attainment JoAnne M. Foody, MD, FACC, FAHA Brigham and Women's Hospital, Boston, MA Disclosures Consultant for Merck and Pfizer Why Address Adherence? Increasing

More information

Review of Controlled Drugs and Substances Act

Review of Controlled Drugs and Substances Act Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A

More information

Rich Segal, R.Ph., Ph.D. Professor and Associate Dean University of Florida

Rich Segal, R.Ph., Ph.D. Professor and Associate Dean University of Florida Exploring Barriers to Medication Adherence and Strategies for Improving Adherence for Asthma Rich Segal, R.Ph., Ph.D. Professor and Associate Dean University of Florida Presentation Objectives Understand

More information

Impact of Counseling on Patient Caretaker s Knowledge and Medication Adherence to Paediatric Antiepileptic Drug Therapy

Impact of Counseling on Patient Caretaker s Knowledge and Medication Adherence to Paediatric Antiepileptic Drug Therapy International Journal of Science and Healthcare Research Vol.3; Issue: 4; Oct.-Dec. 2018 Website: www.ijshr.com Original Research Article ISSN: 2455-7587 Impact of Counseling on Patient Caretaker s Knowledge

More information

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics

More information

Medication Adherence: How Much is Enough?

Medication Adherence: How Much is Enough? Medication Adherence: How Much is Enough? Terrence F. Blaschke, M.D. Senior Program Officer, GH Discovery and Translational Sciences Bill and Melinda Gates Foundation Professor of Medicine and of Molecular

More information

Changing the Tide. An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs

Changing the Tide. An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs Changing the Tide An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs Ken Hahlweg MD, CCFP, FCFP Assistant Professor Department of Family Medicine

More information

HIV: The Great Debate On Clinical Approach Vs. Cost Considerations

HIV: The Great Debate On Clinical Approach Vs. Cost Considerations M E D I C A ID H E A L T H P L A N S O F AMERICA HIV: The Great Debate On Clinical Approach Vs. Cost Considerations Steve Miller, MD Chief Medical Officer October 2018 HIV IMPACT: 1.1M Americans affected

More information

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and effective. Before any drug is approved for marketing

More information

MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL

MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL JENNIFER BUSSELL MD FACP INSTITUTE FOR HEALTHCARE IMPROVEMENT 15 TH ANNUAL INTERNATIONAL SUMMIT ON IMPROVING PATIENT CARE IN THE OFFICE PRACTICE AND

More information

Addressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust

Addressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust Addressing Prescription Drug Abuse Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust Outline 1. Prescription Drug Monitoring Programs 2. Federal policy landscape including

More information

RESEARCH NOTE A STEP-WISE APPROACH TO FIND A VALID AND FEASIBLE METHOD TO DETECT NON-ADHERENCE TO TUBERCULOSIS DRUGS

RESEARCH NOTE A STEP-WISE APPROACH TO FIND A VALID AND FEASIBLE METHOD TO DETECT NON-ADHERENCE TO TUBERCULOSIS DRUGS RESEARCH NOTE A STEP-WISE APPROACH TO FIND A VALID AND FEASIBLE METHOD TO DETECT NON-ADHERENCE TO TUBERCULOSIS DRUGS R Ruslami 1, R van Crevel 2, E van de Berge 2, B Alisjahbana 3 and RE Aarnoutse 4 1

More information

A Gathering Storm: Evaluating Perioperative Opioids

A Gathering Storm: Evaluating Perioperative Opioids A Gathering Storm: Evaluating Perioperative Opioids Michael Bottros, MD Disclosure Nothing to disclose 1 Learning Objectives Describe the history of opioid prescribing practices in the United States Describe

More information

Opioids drive continued increase in drug overdose deaths

Opioids drive continued increase in drug overdose deaths CDC: Drug overdose deaths increase for 11th consecutive year Opioids drive continued increase in drug overdose deaths Atlanta, GA, USA (February 20, 2013) - Drug overdose deaths increased for the 11th

More information

2/9/2017 DISCLOSURES MOTIVATIONAL INTERVIEWING TO PROMOTE BEHAVIOR CHANGE LEARNING OBJECTIVES WHY PHARMACISTS AND TECHNICIANS

2/9/2017 DISCLOSURES MOTIVATIONAL INTERVIEWING TO PROMOTE BEHAVIOR CHANGE LEARNING OBJECTIVES WHY PHARMACISTS AND TECHNICIANS MOTIVATIONAL INTERVIEWING TO PROMOTE BEHAVIOR CHANGE DISCLOSURES The presenter has no actual or potential conflicts of interest in relation to this presentation. Sarah E. Kelling, PharmD, MPH, BCACP Clinical

More information

I f i h a 5 0 p i l l a n d t a k o n e e v e 6 h o u r s h o w m a n w o u l d b l e f t i n d a y s

I f i h a 5 0 p i l l a n d t a k o n e e v e 6 h o u r s h o w m a n w o u l d b l e f t i n d a y s I f i h a 5 0 p i l l a n d t a k o n e e v e 6 h o u r s h o w m a n w o u l d b l e f t i n d a y s Results 1-20 of 77. I was prescribed 30 percocet and was told to take 1 tablet every 4-6 hours as needed

More information

Disease management: understanding and addressing the needs of mainstream consumers

Disease management: understanding and addressing the needs of mainstream consumers Disease management: understanding and addressing the needs of mainstream consumers Melanie Felgate Senior Consumer Insights Analyst Food Matters Live 23 November, 2016 Agenda Introduction Consumer Drivers

More information

D. Gillespie, K. Hood, A. Williams, R. Stenson, C.S.J. Probert and A.B. Hawthorne Clinical Trials Methodology Conference, Bristol 2011

D. Gillespie, K. Hood, A. Williams, R. Stenson, C.S.J. Probert and A.B. Hawthorne Clinical Trials Methodology Conference, Bristol 2011 Use of the Medication Event Monitoring System for assessing medication adherence for chronic conditions: Results from a 12 month trial of patients in remission with ulcerative colitis D. Gillespie, K.

More information

Behavioral Health in PACE: Substance Abuse

Behavioral Health in PACE: Substance Abuse Behavioral Health in PACE: Substance Abuse NPA s Quality Symposium 2017 June 9th, 2017 Bharati Srivastava MD MBA FACP AGSF Mercy LIFE Sharon Hill Mercy LIFE Southeastern PA Trinity Health Inc. Objectives

More information

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN State Senator Alberta Darling A NATIONAL PROBLEM According to the 2014 National Survey on Drug Use and Health: 435,000 Americans have used heroin

More information

ABC Project update. in the field of adherence research. toward better terminology and taxonomy

ABC Project update. in the field of adherence research. toward better terminology and taxonomy ABC Project update toward better terminology and taxonomy in the field of adherence research Assoc. Prof. Przemyslaw Kardas, MD PhD Director, First Department of Family Medicine Medical University of Lodz,

More information

PEOS. Powering Patient Engagement in Hepatitis C treatment in Community Settings.

PEOS. Powering Patient Engagement in Hepatitis C treatment in Community Settings. PEOS Powering Patient Engagement in Hepatitis C treatment in Community Settings. INTRODUCTION Hepatitis C is a liver infection caused by the hepatitis C Virus which can result in inflammation and fibrosis

More information

Management Options for Opioid Dependence:

Management Options for Opioid Dependence: Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice

More information

CCTs and HIV care: Preliminary results and priority areas for intervention

CCTs and HIV care: Preliminary results and priority areas for intervention CCTs and HIV care: Preliminary results and priority areas for intervention Harsha Thirumurthy, Ph.D. Gillings School of Global Public Health UNC-Chapel Hill Outline 1. Background on HIV treatment, adherence

More information

Coalition Strategies Across The Continuum of Care

Coalition Strategies Across The Continuum of Care Coalition Strategies Across The Continuum of Care Dorothy J. Chaney M.Ed. CADCA Consultant Building Safe, Healthy, and Drug Free Communities Overview and Objectives: By completing this training participants

More information

Using Predictive Analytics to Save Lives

Using Predictive Analytics to Save Lives March 2018 1 Using Predictive Analytics to Save Lives Presented by Sybil Klaus MD MPH, MITRE, and James Fackler MD, Johns Hopkins University School of Medicine Approved for Public Release; Distribution

More information

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / /

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / / COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION Name Birthdate / / Home phone ( ) - Cell phone ( ) - Please answer the following questions which will help

More information

Methadone Maintenance 101

Methadone Maintenance 101 Methadone Maintenance 101 OTP/DAILY DOSING CLINICS - ANDREW PUTNEY MD Conflicts of Interest - Employed by Acadia HealthCare 1 Why Methadone? At adequate doses methadone decreases opioid withdrawal symptoms

More information

What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD May 5, 2017

What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD May 5, 2017 What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD kpfeifer@chcf.org May 5, 2017 Beth Name and picture changed What we believed then Opioids are safer than alternatives

More information

Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017

Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017 Prescription Drug Monitoring Program Update Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017 Objectives Brief historical overview of opioids Review of PDMP information Discuss ideas from

More information

CDS Coalition Pharmaceutical Use Cases

CDS Coalition Pharmaceutical Use Cases CDS Coalition Pharmaceutical Use Cases There are several types of decisions in relation to the proper use of pharmaceuticals that standalone software can support: 1. Is the patient a candidate for the

More information

OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse

OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse Advances in pharmacologic therapy have improved quality of life for patients living with pain, ADHD, and other conditions.

More information

Safe Medication Practices

Safe Medication Practices Safe medication practices for life. Slide 1 Safe Medication Practices Facilitator Talking Points Welcome to today s program, Generation Rx: Safe Medication Practices for Life. You may be asking yourself,

More information

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able

More information

Introduction. Arthritis Foundation Arthritis Advocacy Toolkit

Introduction. Arthritis Foundation Arthritis Advocacy Toolkit Introduction As a Champion of Yes, you can help knock down barriers to easy and affordable care and use your Yes attitude to make a difference. Amplify your message by adding your voice to ours. The actions

More information

Pediatric Adherence for the School Nurse

Pediatric Adherence for the School Nurse Pediatric Adherence for the School Nurse Eve-Lynn Nelson, Ph.D. Assistant Director, Research KU Center for TeleMedicine (913) 588-2413; enelson2@kumc.edu Generously sponsored through a grant from the Health

More information

Asthma: Chronic Management. Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015

Asthma: Chronic Management. Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015 Asthma: Chronic Management Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015 Global Strategy for Asthma Management and Prevention Evidence-based Implementation

More information

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Predicting and Preventing Readmissions: Opportunities & Challenges. Geraint Lewis MD MPH FRCP FFPH Senior Director Clinical Outcomes and Analytics

Predicting and Preventing Readmissions: Opportunities & Challenges. Geraint Lewis MD MPH FRCP FFPH Senior Director Clinical Outcomes and Analytics Predicting and Preventing Readmissions: Opportunities & Challenges Geraint Lewis MD MPH FRCP FFPH Senior Director Clinical Outcomes and Analytics May 31, 2012 Overview Why is Walgreens Interested in Readmissions?

More information

Polytechnic Institute of Coimbra, Coimbra Health School, Pharmacy, Portugal 2

Polytechnic Institute of Coimbra, Coimbra Health School, Pharmacy, Portugal 2 EspaComp 2016 20 TH ANNUAL MEETING OF THE EUROPEAN SOCIETY FOR PATIENT ADHERENCE, COMPLIANCE AND PERSISTENCE 17-19 NOVEMBER 2016 / LISBON - PORTUGAL Patient-Reported Perceptions of Adverse Events with

More information

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System Session L6 This presenter has nothing to disclose It Takes a Village to Curb the Prescription Opioid Epidemic: Reducing Opioid Over- Prescribing in a Large Integrated Health Care System Joel D. Hyatt,

More information

Each Home Instead Senior Care franchise office is independently owned and operated Home Instead, Inc.

Each Home Instead Senior Care franchise office is independently owned and operated Home Instead, Inc. Each Home Instead Senior Care franchise office is independently owned and operated. 2011 Home Instead, Inc. Modern medicine continues to give us new drugs to ease our pain, cure our ills and extend our

More information

Viral Load Monitoring and Enhanced Adherence Counseling Flipchart. Adults, non-pregnant nor breastfeeding

Viral Load Monitoring and Enhanced Adherence Counseling Flipchart. Adults, non-pregnant nor breastfeeding Viral Load Monitoring and Enhanced Adherence Counseling Flipchart Adults, non-pregnant nor breastfeeding This job tool was created by ICAP at Columbia University with funding from the U.S. President s

More information

IMPACT OF DRUG REBATES ON YOUR PARTICIPANTS AND YOUR PLAN RISK PROFILE Indiana Health and Wellness Summit

IMPACT OF DRUG REBATES ON YOUR PARTICIPANTS AND YOUR PLAN RISK PROFILE Indiana Health and Wellness Summit IMPACT OF DRUG REBATES ON YOUR PARTICIPANTS AND YOUR PLAN RISK PROFILE 2018 Indiana Health and Wellness Summit National Diabetes Volunteer Leadership Council Who We Are Patient advocacy organization committed

More information

Chronic Pain Management with High Dose Opioid Medication

Chronic Pain Management with High Dose Opioid Medication University of Vermont ScholarWorks @ UVM Family Medicine Clerkship Student Projects College of Medicine 2015 Chronic Pain Management with High Dose Opioid Medication Joshua Cohen Follow this and additional

More information

The Prescription Opioid and Heroin Crisis

The Prescription Opioid and Heroin Crisis The Prescription Opioid and Heroin Crisis Dr. Rachel L. Levine Acting Secretary of Health and Physician General Professor of Pediatrics and Psychiatry Penn State College of Medicine Overdose deaths from

More information

Getting Hypertension Under Control

Getting Hypertension Under Control Getting Hypertension Under Control Learning Objectives EXPLAIN the factors involved in patient medication non-adherence. OUTLINE the results of studies focusing on medication adherence issues in patients

More information